Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.15B | 895.40M | 642.42M | 535.82M | 447.89M | Gross Profit |
1.15B | 895.40M | 642.42M | 535.82M | 447.89M | EBIT |
152.74M | 110.10M | 56.19M | 48.75M | -94.66M | EBITDA |
165.59M | 124.02M | 61.32M | 58.05M | -84.01M | Net Income Common Stockholders |
118.83M | 85.98M | 39.40M | 38.32M | -74.64M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.18B | 863.92M | 774.17M | 206.38M | 299.41M | Total Assets |
3.73B | 2.95B | 2.37B | 2.12B | 1.95B | Total Debt |
119.54M | 128.69M | 128.61M | 128.53M | 128.45M | Net Debt |
-2.07M | 62.80M | 83.17M | 86.42M | 64.99M | Total Liabilities |
2.94B | 2.29B | 1.95B | 1.69B | 1.65B | Stockholders Equity |
794.00M | 661.03M | 421.66M | 426.08M | 303.22M |
Cash Flow | Free Cash Flow | |||
300.89M | 335.03M | 206.61M | 173.13M | 42.64M | Operating Cash Flow |
305.12M | 338.19M | 208.94M | 175.28M | 44.71M | Investing Cash Flow |
-243.69M | -493.81M | -193.38M | -183.01M | -74.93M | Financing Cash Flow |
-4.23M | 130.95M | 2.18M | 1.38M | 56.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $2.46B | 20.37 | 16.03% | ― | 25.88% | 9.45% | |
73 Outperform | $2.09B | 43.09 | 17.95% | ― | 98.66% | ― | |
70 Outperform | $1.21B | 28.25 | 14.40% | ― | 50.21% | 37.28% | |
69 Neutral | $1.22B | 16.69 | 8.75% | 4.41% | 19.05% | 40.69% | |
67 Neutral | $1.91B | 15.98 | 28.75% | 0.97% | 20.89% | 3.25% | |
64 Neutral | $12.67B | 9.74 | 7.58% | 17015.08% | 12.21% | -6.96% | |
47 Neutral | $2.27B | ― | -35.57% | ― | 21.44% | 2.99% |
On May 7, 2025, Skyward Specialty Insurance Group, Inc. held its Annual Meeting of Shareholders. During the meeting, Marcia Dall and Anthony J. Kuczinski were elected as directors, and the compensation of named executive officers was approved. The company decided to hold annual advisory votes on executive compensation until 2031. Additionally, Ernst & Young LLP was ratified as the independent auditors for the fiscal year ending December 31, 2025.
The most recent analyst rating on (SKWD) stock is a Buy with a $54.00 price target. To see the full list of analyst forecasts on Skyward Specialty Insurance Group, Inc. stock, see the SKWD Stock Forecast page.